Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia

Leukemia

Volumn 24, Issue 4, 2010, Pages 877-881

  Allan, J M ^a   Sunter, N J ^a   Bailey, J R ^b   Pettitt, A R ^c   Harris, R J ^c   Pepper, C ^d   Fegan, C ^e   Hall, A G ^a   Deignan, L ^a   Bacon, C M ^a   Pointon, J C ^b   Houlston, R S ^f   Broderick, P ^f   Mainou Fowler, T ^g   Jackson, G H ^h   Summerfield, G ⁱ   Evans, P A ^j   Strefford, J C ^k   Parker, A ^l   Oscier, D ^l   Pratt, G ^m   Allsup, D J ⁿ   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h ROYAL VICTORIA INFIRMARY   (United Kingdom)

ⁱ QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^j LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^k UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^l ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^m BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

ⁿ HULL ROYAL INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CD38 ANTIGEN; GUANOSINE; INTERFERON REGULATORY FACTOR 4; PROTEIN KINASE ZAP 70;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EUROPE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE AMPLIFICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; IMMUNOPHENOTYPING; LETTER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REPRODUCIBILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SURVIVAL TIME; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 77950961443     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.298     Document Type: Letter

References (8)

1. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008; 40: 1204-1210.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon, 2001.
3. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H et al. Guidelines for the diagnosis and treatment of chroniclymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer InstituteFWorking Group 1996 guidelines. Blood 2008; 111: 5446-5456.
4. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
5. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
6. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105-111.
7. Escalante CR, Brass AL, Pongubala JM, Shatova E, Shen L, Singh H et al. Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell 2002; 10: 1097-1105.
8. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation-stage-specific expression of microRNAs in B-lymphocytes and diffuse large B-cell lymphomas. Blood 2008; 113: 3754-3764.